NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1958776854|ref|XP_038966040|]
View 

membrane metallo-endopeptidase-like 1 isoform X3 [Rattus norvegicus]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
6-672 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 782.71  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   6 KPCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQH--RPAVEKAKTLYRSCMNQSVIEKRDSE 83
Cdd:cd08662     2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAadSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  84 PLLNVLDMIGGWPVAMDKWNETmgpkwelerqLAVLNSQFNRRVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSREYYFKE 163
Cdd:cd08662    82 PLKPLLDKIGGLPSLDDLAAEL----------LLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 164 DSHRVREAYLQFMTSVATMLRRDLnlpgetDLVQEEMAQVLHLETHLANATVPQEKRHDVTALYHRMGLEELQERFglKG 243
Cdd:cd08662   152 ENAEIREAYKKYIAKLLELLGADE------EEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA--PS 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 244 FNWTLFIQNVLSSVQvellPNEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEARVDYRKALYG 323
Cdd:cd08662   224 IDWKAYLKALGPPAD----DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSG 299
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 324 TTMEEVRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQEKALNIREQI 403
Cdd:cd08662   300 QKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKI 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 404 GYPDYILedNNRHLDEEYSSLTFSEDlYFENGLQNLKNNAQRSLKKLREKVDQNLWIIGAAVVNAFYSPNRNLIVFPAGI 483
Cdd:cd08662   380 GYPDKWR--DYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGI 456
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 484 LQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCMIYQYSNFswELADNQNV 563
Cdd:cd08662   457 LQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY--EVPPGLHV 534
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 564 NGFSTLGENIADNGGVRQAYKAYLQWLAEGGRDQrLPGLNLTYAQLFFINYAQVWCGSYRPEFAIQSIKTDVHSPLKYRV 643
Cdd:cd08662   535 NGKLTLGENIADNGGLRLAYRAYKKWLKENGPEL-PGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRV 613
                         650       660
                  ....*....|....*....|....*....
gi 1958776854 644 LGSLQNLPGFSEAFHCPRGSPMHPMNRCR 672
Cdd:cd08662   614 NGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
6-672 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 782.71  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   6 KPCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQH--RPAVEKAKTLYRSCMNQSVIEKRDSE 83
Cdd:cd08662     2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAadSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  84 PLLNVLDMIGGWPVAMDKWNETmgpkwelerqLAVLNSQFNRRVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSREYYFKE 163
Cdd:cd08662    82 PLKPLLDKIGGLPSLDDLAAEL----------LLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 164 DSHRVREAYLQFMTSVATMLRRDLnlpgetDLVQEEMAQVLHLETHLANATVPQEKRHDVTALYHRMGLEELQERFglKG 243
Cdd:cd08662   152 ENAEIREAYKKYIAKLLELLGADE------EEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA--PS 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 244 FNWTLFIQNVLSSVQvellPNEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEARVDYRKALYG 323
Cdd:cd08662   224 IDWKAYLKALGPPAD----DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSG 299
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 324 TTMEEVRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQEKALNIREQI 403
Cdd:cd08662   300 QKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKI 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 404 GYPDYILedNNRHLDEEYSSLTFSEDlYFENGLQNLKNNAQRSLKKLREKVDQNLWIIGAAVVNAFYSPNRNLIVFPAGI 483
Cdd:cd08662   380 GYPDKWR--DYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGI 456
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 484 LQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCMIYQYSNFswELADNQNV 563
Cdd:cd08662   457 LQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY--EVPPGLHV 534
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 564 NGFSTLGENIADNGGVRQAYKAYLQWLAEGGRDQrLPGLNLTYAQLFFINYAQVWCGSYRPEFAIQSIKTDVHSPLKYRV 643
Cdd:cd08662   535 NGKLTLGENIADNGGLRLAYRAYKKWLKENGPEL-PGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRV 613
                         650       660
                  ....*....|....*....|....*....
gi 1958776854 644 LGSLQNLPGFSEAFHCPRGSPMHPMNRCR 672
Cdd:cd08662   614 NGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
1-674 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 625.25  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   1 MDQSKKPCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQHRPA--VE-KAKTLYRSCMNQSVI 77
Cdd:COG3590    33 MDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAgsDEqKIGDLYASFMDEAAI 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  78 EKRDSEPLLNVLDMIggwpvamdkwnETMGPKWELERQLAVLNSQFNRrVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSR 157
Cdd:COG3590   113 EALGLAPLKPDLARI-----------DAIKDKADLAALLAALHRAGVG-GLFGFGVDADLKNSTRYIAYLGQGGLGLPDR 180
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 158 EYYFKEDSH--RVREAYLQFmtsVATMLRrdlnLPGETDLVQEEMAQ-VLHLETHLANATVPQEKRHDVTALYHRMGLEE 234
Cdd:COG3590   181 DYYLKDDEKsaEIRAAYVAH---VAKMLE----LAGYDEADAAAAAEaVLALETALAKAHWSRVELRDPEKTYNPMTVAE 253
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 235 LQERFglKGFNWTLFiqnvLSSVQVELLpnEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEAR 314
Cdd:COG3590   254 LAKLA--PGFDWDAY----LKALGLPAV--DEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAFVDAN 325
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 315 VD-YRKALYGTTMEEVRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQ 393
Cdd:COG3590   326 FDfYGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKAL 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 394 EKALNIREQIGYPDYilednnrhlDEEYSSLTFSEDLYFENGLQNLKNNAQRSLKKLREKVDQNLWIIGAAVVNAFYSPN 473
Cdd:COG3590   406 EKLAAFTPKIGYPDK---------WRDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQTVNAYYNPT 476
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 474 RNLIVFPAGILQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCMIYQYSNF 553
Cdd:COG3590   477 MNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAY 556
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 554 swELADNQNVNGFSTLGENIADNGGVRQAYKAYLQWLAeggrDQRLPGLN-LTYAQLFFINYAQVWCGSYRPEFAIQSIK 632
Cdd:COG3590   557 --EPLPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLK----GKEAPVIDgFTGDQRFFLGWAQVWRSKARDEALRQRLA 630
                         650       660       670       680
                  ....*....|....*....|....*....|....*....|....
gi 1958776854 633 TDVHSPLKYRVLGSLQNLPGFSEAFHCPRGSPMH--PMNRCRIW 674
Cdd:COG3590   631 TDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYlaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
7-406 9.38e-151

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 441.74  E-value: 9.38e-151
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   7 PCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQH--RPAVEKAKTLYRSCMNQSVIEKRDSEP 84
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASEsdPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  85 LLNVLDMIGGWPVAMDKWnetmgpkwELERQLAVLNSqFNRRVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSREYYFKED 164
Cdd:pfam05649  81 LKPLLDEIGGPLANKDKF--------DLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 165 SHR---VREAYLQFMTSVATMLrrdlnlpGETDLVQEEMAQVLHLETHLANATVPQEKRHDVTALYHRMGLEELQERFgl 241
Cdd:pfam05649 152 DEKsaeIREAYKAYIAKLLTLL-------GASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLA-- 222
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 242 KGFNWTLFIQNVLssvqVELLPNEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEARVDYRKAL 321
Cdd:pfam05649 223 PGIDWKAYLNAAG----LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 322 YGTTMEEvRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQEKALNIRE 401
Cdd:pfam05649 299 SGTKQRP-RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTV 377

                  ....*
gi 1958776854 402 QIGYP 406
Cdd:pfam05649 378 KIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
6-672 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 782.71  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   6 KPCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQH--RPAVEKAKTLYRSCMNQSVIEKRDSE 83
Cdd:cd08662     2 DPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAadSSAEQKAKDFYKSCMDEEAIEKLGLK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  84 PLLNVLDMIGGWPVAMDKWNETmgpkwelerqLAVLNSQFNRRVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSREYYFKE 163
Cdd:cd08662    82 PLKPLLDKIGGLPSLDDLAAEL----------LLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 164 DSHRVREAYLQFMTSVATMLRRDLnlpgetDLVQEEMAQVLHLETHLANATVPQEKRHDVTALYHRMGLEELQERFglKG 243
Cdd:cd08662   152 ENAEIREAYKKYIAKLLELLGADE------EEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA--PS 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 244 FNWTLFIQNVLSSVQvellPNEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEARVDYRKALYG 323
Cdd:cd08662   224 IDWKAYLKALGPPAD----DPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKALSG 299
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 324 TTMEEVRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQEKALNIREQI 403
Cdd:cd08662   300 QKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKI 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 404 GYPDYILedNNRHLDEEYSSLTFSEDlYFENGLQNLKNNAQRSLKKLREKVDQNLWIIGAAVVNAFYSPNRNLIVFPAGI 483
Cdd:cd08662   380 GYPDKWR--DYSALDIYYDDLNVSDS-YFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGI 456
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 484 LQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCMIYQYSNFswELADNQNV 563
Cdd:cd08662   457 LQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY--EVPPGLHV 534
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 564 NGFSTLGENIADNGGVRQAYKAYLQWLAEGGRDQrLPGLNLTYAQLFFINYAQVWCGSYRPEFAIQSIKTDVHSPLKYRV 643
Cdd:cd08662   535 NGKLTLGENIADNGGLRLAYRAYKKWLKENGPEL-PGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRV 613
                         650       660
                  ....*....|....*....|....*....
gi 1958776854 644 LGSLQNLPGFSEAFHCPRGSPMHPMNRCR 672
Cdd:cd08662   614 NGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
1-674 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 625.25  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   1 MDQSKKPCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQHRPA--VE-KAKTLYRSCMNQSVI 77
Cdd:COG3590    33 MDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAgsDEqKIGDLYASFMDEAAI 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  78 EKRDSEPLLNVLDMIggwpvamdkwnETMGPKWELERQLAVLNSQFNRrVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSR 157
Cdd:COG3590   113 EALGLAPLKPDLARI-----------DAIKDKADLAALLAALHRAGVG-GLFGFGVDADLKNSTRYIAYLGQGGLGLPDR 180
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 158 EYYFKEDSH--RVREAYLQFmtsVATMLRrdlnLPGETDLVQEEMAQ-VLHLETHLANATVPQEKRHDVTALYHRMGLEE 234
Cdd:COG3590   181 DYYLKDDEKsaEIRAAYVAH---VAKMLE----LAGYDEADAAAAAEaVLALETALAKAHWSRVELRDPEKTYNPMTVAE 253
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 235 LQERFglKGFNWTLFiqnvLSSVQVELLpnEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEAR 314
Cdd:COG3590   254 LAKLA--PGFDWDAY----LKALGLPAV--DEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAFVDAN 325
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 315 VD-YRKALYGTTMEEVRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQ 393
Cdd:COG3590   326 FDfYGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIENLDWMSPETKAKAL 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 394 EKALNIREQIGYPDYilednnrhlDEEYSSLTFSEDLYFENGLQNLKNNAQRSLKKLREKVDQNLWIIGAAVVNAFYSPN 473
Cdd:COG3590   406 EKLAAFTPKIGYPDK---------WRDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEWGMTPQTVNAYYNPT 476
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 474 RNLIVFPAGILQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCMIYQYSNF 553
Cdd:COG3590   477 MNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEARTKKLVAQYDAY 556
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 554 swELADNQNVNGFSTLGENIADNGGVRQAYKAYLQWLAeggrDQRLPGLN-LTYAQLFFINYAQVWCGSYRPEFAIQSIK 632
Cdd:COG3590   557 --EPLPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLK----GKEAPVIDgFTGDQRFFLGWAQVWRSKARDEALRQRLA 630
                         650       660       670       680
                  ....*....|....*....|....*....|....*....|....
gi 1958776854 633 TDVHSPLKYRVLGSLQNLPGFSEAFHCPRGSPMH--PMNRCRIW 674
Cdd:COG3590   631 TDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYlaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
7-406 9.38e-151

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 441.74  E-value: 9.38e-151
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854   7 PCDNFYQYACGGWLRHHVIPETNSRYSVFDILRDELEVILKGVLEDSSVQH--RPAVEKAKTLYRSCMNQSVIEKRDSEP 84
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASEsdPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854  85 LLNVLDMIGGWPVAMDKWnetmgpkwELERQLAVLNSqFNRRVLIDLFIWNDDQNSSRHVIYIDQPTLGMPSREYYFKED 164
Cdd:pfam05649  81 LKPLLDEIGGPLANKDKF--------DLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDR 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 165 SHR---VREAYLQFMTSVATMLrrdlnlpGETDLVQEEMAQVLHLETHLANATVPQEKRHDVTALYHRMGLEELQERFgl 241
Cdd:pfam05649 152 DEKsaeIREAYKAYIAKLLTLL-------GASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLA-- 222
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 242 KGFNWTLFIQNVLssvqVELLPNEEVVVYGIPYLENLEEIIDVFPAQTLQNYLVWRLVLDRIGSLSQRFKEARVDYRKAL 321
Cdd:pfam05649 223 PGIDWKAYLNAAG----LPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 322 YGTTMEEvRWRECVSYVNSNMESAVGSLYIKRAFSKDSKSIVSELIEKIRSVFVDNLDELNWMDEESKKKAQEKALNIRE 401
Cdd:pfam05649 299 SGTKQRP-RWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTV 377

                  ....*
gi 1958776854 402 QIGYP 406
Cdd:pfam05649 378 KIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
467-673 1.14e-85

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 267.36  E-value: 1.14e-85
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 467 NAFYSPNRNLIVFPAGILQPPFFSKDQPQALNFGGIGMVIGHEITHGFDDNGRNFDKNGNMLDWWSNFSARHFRQQSQCM 546
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958776854 547 IYQYSNFSwELADNQNVNGFSTLGENIADNGGVRQAYKAYLQWLaeGGRDQRLPGL-NLTYAQLFFINYAQVWCGSYRPE 625
Cdd:pfam01431  81 IEQYSEYT-PPDGTKCANGTLTLGENIADLGGLTIALRAYKKLL--SANETVLPGFeNLTPDQLFFRGAAQIWCMKQSPA 157
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 1958776854 626 FAIQSIKTDVHSPLKYRVLGSLQNLPGFSEAFHCPRGSPMHPMNRCRI 673
Cdd:pfam01431 158 EVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
461-524 2.97e-06

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 46.32  E-value: 2.97e-06
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1958776854 461 IGAAVVNAFYSPNrNLIVFPAGILQppffskdqpqalNFGGIGMVIGHEITHGFDDNGRNFDKN 524
Cdd:cd09594    37 VEVNAYNAMWIPS-TNIFYGAGILD------------TLSGTIDVLAHELTHAFTGQFSNLMYS 87
M48C_Oma1_like cd07331
Peptidase M48C, integral membrane endopeptidase; This subfamily contains peptidase M48C Oma1 ...
445-512 8.36e-03

Peptidase M48C, integral membrane endopeptidase; This subfamily contains peptidase M48C Oma1 (also called mitochondrial metalloendopeptidase OMA1) protease homologs that are mostly uncharacterized. Oma1 is part of the quality control system in the inner membrane of mitochondria, with its catalytic site facing the matrix space. It cleaves and thereby promotes the turnover of mistranslated or misfolded membrane proteins. Oma1 can cleave the misfolded multi-pass membrane protein Oxa1, thus exerting a function similar to the ATP-dependent m-AAA protease for quality control of inner membrane proteins; it cleaves a misfolded polytopic membrane protein at multiple sites. It has been proposed that in the absence of m-AAA protease, proteolysis of Oxa1 is mediated by Oma1 in an ATP-independent manner. Oma1 is part of highly conserved mitochondrial metallopeptidases, with homologs present in higher eukaryotes, eubacteria and archaebacteria, all containing the zinc binding motif (HEXXH). It forms a high molecular mass complex in the inner membrane, possibly a homo-hexamer.


Pssm-ID: 320690 [Multi-domain]  Cd Length: 187  Bit Score: 37.94  E-value: 8.36e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1958776854 445 RSLKKLREKVDQNLW---IIGAAVVNAFYSPNRNLIVFpAGILqpPFFSKDQpqalnfgGIGMVIGHEITH 512
Cdd:cd07331    10 AAAGDDPPQSAGWDWevhVIDSPEVNAFVLPGGKIFVF-TGLL--PVAKNDD-------ELAAVLGHEIAH 70
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH